Cytel

📍 Cambridge, United States🗓 Founded 1987👥 1,533 employees💰 Last funded Jan 2021
Cytel is the world’s leading data-science CRO, driving advancements in human health through robust analytics and innovative clinical trial software. For nearly four decades, we have set the standard in adaptive trial design, leveraging extensive data insights to inform strategy throughout every phase of drug development and commercialization. Our mission is clear: accelerate drug development, enhance success rates, and deliver better patient outcomes. With a comprehensive suite of services from innovative trial design to end-to-end biometrics and real-world evidence, our specialized, multidisciplinary team ensures optimal strategies for preclinical research, trial execution, market access, and reimbursement. Headquartered in Cambridge, Massachusetts, Cytel has a global presence with over 2,000 employees across North America, Europe, and Asia. Learn more about how Cytel is harnessing the power of data to advance human health at www.cytel.com.
2
Total investors
0
Early stage
0
Mid stage
0
Late stage
1987
Founded
Investor geography1 country
United States
2
Frequently asked questions
Who invested in Cytel?
Cytel has 2 investors on record on gritt.io.
When did Cytel last raise funding?
The most recent investment in Cytel recorded on gritt.io was in January 2021.
When was Cytel founded?
Cytel was founded in 1987.
What industry is Cytel in?
Cytel operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Cytel based?
Cytel is headquartered in Cambridge, United States.